Bone Biologics (BBLG) Appoints Phillip T. Meikle to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 11/4/2026

1. AMD
2. AMGN
3. BKNG
4. DOX
5. DUOL
6. ANET
7. SWKS
8. XYZ
9. FISV
10. CVS

Go back to Bone Biologics (BBLG) Appoints Phillip T. Meikle to its Board

Bone Biologics Appoints Phillip T. Meikle to its Board of Directors

October 21, 2024 8:00 AM EDT

Brings 30+ years of commercial experience in the orthopedic and spine industry

BURLINGTON, Mass.--(BUSINESS WIRE)-- Bone Biologics Corporation (Bone Biologics or the Company) (Nasdaq: BBLG, BBLGW), a developer of orthobiologic products for spine fusion markets, announces the appointment of Phillip T. Meikle to the Companys board of directors, effective immediately. Mr. Meikle succeeds Don R. Hankey, who retired from the Board following seven years of service. The number of directors of Bone Biologics remains at four.

Mr. Meikle most recently was president and chief executive officer of Biosystems of New England, Inc., an... More